1 false false false false false false false false false true false false false false false false No description of principal activity 2022-04-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 06504132 2022-04-01 2023-06-30 06504132 2023-06-30 06504132 2021-04-01 2022-03-31 06504132 2022-03-31 06504132 bus:LeadAgentIfApplicable 2022-04-01 2023-06-30 06504132 bus:CompanySecretary1 2022-04-01 2023-06-30 06504132 core:WithinOneYear 2023-06-30 06504132 core:WithinOneYear 2022-03-31 06504132 core:AfterOneYear 2023-06-30 06504132 core:AfterOneYear 2022-03-31 06504132 core:RestatedAmount 2022-03-31 06504132 bus:Director3 2022-04-01 2023-06-30 06504132 bus:Micro-entities 2022-04-01 2023-06-30 06504132 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-06-30 06504132 bus:FullAccounts 2022-04-01 2023-06-30 06504132 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-06-30 06504132 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-06-30
COMPANY REGISTRATION NUMBER: 06504132

Reynard Health Supplies (UK) Ltd

Unaudited Financial Statements

30 June 2023

Reynard Health Supplies (UK) Ltd

Financial Statements

Period from 1 April 2022 to 30 June 2023

Contents | Page

Accountants report to the board of directors on the preparation of the unaudited statutory financial statements | 1

Income statement | 2

Statement of financial position and the notes to the financial statements | 3

Reynard Health Supplies (UK) Ltd

Accountants Report to the Board of Directors on the Preparation of the Unaudited Statutory Financial Statements of Reynard Health Supplies (UK) Ltd

Period from 1 April 2022 to 30 June 2023
As described on the statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the period ended 30 June 2023, which comprise the income statement, statement of financial position and the notes to the financial statements. You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
ACE ACCOUNTANTS LTD Accountants
The White House Denchworth Road Grove Oxon OX12 0AR
24 August 2023

Reynard Health Supplies (UK) Ltd

Income Statement

Period from 1 April 2022 to 30 June 2023

| Period from |
| 1 Apr 22 to | Year to
| 30 Jun 23 | 31 Mar 22
| £ | £
Turnover | 302,597 | 265,533

Cost of raw materials and consumables | 205,887 | 196,886

Staff costs | 52,954 | 45,494

Depreciation and other amounts written off assets | 1,884 | 624

Other charges | 66,735 | 81,201

| --------- | ---------
Loss | ( 24,863) | ( 58,672)
| --------- | ---------

Reynard Health Supplies (UK) Ltd

Statement of Financial Position

30 June 2023

| Period from |
| 1 Apr 22 to | Year to
| 30 Jun 23 | 31 Mar 22
| £ | £ | £
Fixed assets |  | 5,500 | 1,383
|  | ------- | -------

Current assets |  | 93,588 | 88,418

Creditors: amounts falling due within one year |  | 96,593 | 62,558
|  | -------- | --------
Net current (liabilities)/assets |  | ( 3,005) | 25,860
|  | ------- | --------
Total assets less current liabilities |  | 2,495 | 27,243

Creditors: amounts falling due after more than one year |  | 186,277 | 186,277

Accruals and deferred income |  | 3,000 | 2,885
|  | --------- | ---------
|  | (186,782) | (161,919)
|  | --------- | ---------

Capital and reserves |  | ( 186,782) | ( 161,919)
|  | --------- | ---------

Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the period amounted to 1 (2022: 2 ).
For the period ending 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions.
These financial statements were approved by the board of directors and authorised for issue on 24 August 2023 , and are signed on behalf of the board by:
Mr B J Arthur Director
Company registration number: 06504132
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is The White House, Denchworth Road, Grove, Wantage, OX12 0AR, Oxon.